Korrektur
Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”
The FASEB Journal · 31.05.2026 · 40 (10)
DOI: 10.1096/fj.202602388 ↗Kurz gefasst
Korrektur in der Zeitschrift The FASEB Journal, online erschienen am 15.05.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”. The FASEB Journal, 40(10). https://doi.org/10.1096/fj.202602388
Vancouver
Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”. The FASEB Journal. 2026;40(10). doi:10.1096/fj.202602388
BibTeX
@article{euvimed2026,
title = {Correction to “Belzutifan Attenuates Choroidal Neovascularization by Suppressing the HIF ‐2α/ PAI ‐1 Axis”},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {10},
doi = {10.1096/fj.202602388}
}
EUVIMED